Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study

To determine the long-term effects of ranibizumab (RBZ) in patients with diabetic macular edema (DME). Prospective, randomized, interventional, multicenter clinical trial. One hundred twenty-six patients with DME. Subjects were randomized 1:1:1 to receive 0.5 mg RBZ at baseline and months 1, 3, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Jg. 117; H. 11; S. 2146
Hauptverfasser:	Nguyen, Quan Dong, Shah, Syed Mahmood, Khwaja, Afsheen A, Channa, Roomasa, Hatef, Elham, Do, Diana V, Boyer, David, Heier, Jeffery S, Abraham, Prema, Thach, Allen B, Lit, Eugene S, Foster, Bradley S, Kruger, Erik, Dugel, Pravin, Chang, Thomas, Das, Arup, Ciulla, Thomas A, Pollack, John S, Lim, Jennifer I, Eliott, Dean, Eliot, Dean, Campochiaro, Peter A
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.11.2010
Schlagworte:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Combined Modality Therapy Diabetic Retinopathy - drug therapy Fluorescein Angiography Humans Injections Laser Coagulation Macular Edema - drug therapy Prospective Studies Ranibizumab Retreatment Time Factors Tomography, Optical Coherence Treatment Outcome Visual Acuity - physiology Vitreous Body
ISSN:	1549-4713, 1549-4713
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!